Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
GERN

Price
1.80
Stock movement up
+0.15 (9.09%)
Company name
Geron Corporation
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
1.15B
Ent value
1.42B
Price/Sales
6.25
Price/Book
5.14
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
22.50
PEG
-
EPS growth
-14.31%
1 year return (CAGR)
-35.48%
3 year return (CAGR)
-15.75%
5 year return (CAGR)
-2.57%
10 year return (CAGR)
-3.67%
Last updated: 2026-03-13

DIVIDENDS

GERN does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales6.25
Price to Book5.14
EV to Sales7.70

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count638.36M
EPS (TTM)-0.13
FCF per share (TTM)-0.17

Income statement

Loading...
Income statement data
Revenue (TTM)183.88M
Gross profit (TTM)158.07M
Operating income (TTM)-53.84M
Net income (TTM)-85.78M
EPS (TTM)-0.13
EPS (1y forward)0.08

Margins

Loading...
Margins data
Gross margin (TTM)85.96%
Operating margin (TTM)-29.28%
Profit margin (TTM)-46.65%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash79.44M
Net receivables0.00
Total current assets520.27M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets570.54M
Accounts payable0.00
Short/Current long term debt0.00
Total current liabilities113.82M
Total liabilities346.95M
Shareholder's equity223.59M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-111.04M
Capital expenditures (TTM)259.00K
Free cash flow (TTM)-111.30M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-38.37%
Return on Assets-15.04%
Return on Invested Capital-38.37%
Cash Return on Invested Capital-49.78%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1.65
Daily high1.85
Daily low1.65
Daily Volume20.6M
All-time high65.99
1y analyst estimate3.40
Beta0.62
EPS (TTM)-0.13
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
GERNS&P500
Current price drop from All-time high-97.27%-1.82%
Highest price drop-98.66%-56.47%
Date of highest drop18 Mar 20209 Mar 2009
Avg drop from high-85.95%-10.84%
Avg time to new high240 days12 days
Max time to new high6526 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
GERN (Geron Corporation) company logo
Marketcap
1.15B
Marketcap category
Small-cap
Description
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
Employees
229
Investor relations
-
SEC filings
CEO
John A. Scarlett
Country
USA
City
Menlo Park
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...